An improved route to synthesize deglyco-bleomycin A2, the aglycon of bleomycin A2, aiming at the total synthesis of bleomycin is described. The new route is characterized by the stepwise elongation of the amino acid constituents and the use of a thiol ester obtained by aldol condensation. Deglyco-b
Total synthesis of deglyco-bleomycin A2
โ Scribed by Tomohisa Takita; Yoji Umezawa; Sei-ichi Saito; Hajime Morishima; Hamao Umezawa; Yasuhiko Muraoka; Masanobu Suzuki; Masami Otsuka; Susumu Kobayashi; Masaji Ohno
- Book ID
- 104243636
- Publisher
- Elsevier Science
- Year
- 1981
- Tongue
- French
- Weight
- 235 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0040-4039
No coin nor oath required. For personal study only.
โฆ Synopsis
Surmnary: Deglyco-bleomycin A2, the aglycon of bleomycin time. A2, has been synthesized for the first Bleomycin (BIM) is an antitumor antibiotic clinically used in the treatment of squamous cell carcinoma and malignant lymphoma. 1 In addition to its medicinal importance, BLM is of great interest because of its complicated structure 2,3 and unique mechanism of action. 3-6 BLM A2 (&-a) is the major component of the BLM clinically used at the present time. Deglyco-BLM A2 (L-b), the
๐ SIMILAR VOLUMES